指南与共识乳腺外科

乳腺癌低价值手术的「明智选择」推荐去实施:系统综述

Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review.
指南 / 共识 · JAMA Surg · 2020-01-01

该系统综述依据PRISMA指南检索Ovid、Embase、CINAHL和Cochrane数据库,评估乳腺癌4项低价值手术的去实施程度。结果显示腋窝淋巴结清扫和切缘再切除使用率下降,而对侧预防性乳房切除术和70岁及以上患者的前哨淋巴结活检使用率仍高。

要点

  • 腋窝淋巴结清扫率从2011年44%降至2013年25%-28%,切缘再切除率下降近40%。
  • 对侧预防性乳房切除术率持续上升,2010-2012年占全乳切除术28%-30%。
  • 70岁及以上低风险乳腺癌患者前哨淋巴结活检率持续>80%。

核心结论

  • 4项低价值乳腺癌手术的去实施程度不一,腋窝淋巴结清扫和切缘再切除使用减少,而对侧预防性乳房切除术和前哨淋巴结活检使用仍高。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索Ovid、Embase、CINAHL和Cochrane数据库,纳入与「明智选择」推荐相关的原始研究。

主要发现

  • 有限淋巴结病变患者腋窝淋巴结清扫全国率从2011年44%降至2012年30%-34%、2013年25%-28%。
  • 乳房肿瘤切除切缘再切除全国率从共识声明发表前的16%-34%降至发表后的14%-18%。
  • 对侧预防性乳房切除术率逐年上升,2010-2012年占所有乳腺癌乳房切除术的28%-30%,1998年<2%。
  • 70岁及以上低风险乳腺癌患者前哨淋巴结活检率持续>80%(范围80%-88%)。
  • 对侧预防性乳房切除术高使用率相关因素包括年轻年龄、白人种族、较高社会经济地位和乳房重建可及性。

关键数值与推荐

  • 「明智选择」推荐的4项低价值手术:有限淋巴结病变行腋窝淋巴结清扫、浸润癌切缘近但阴性行再切除、平均风险单侧癌行对侧预防性乳房切除术、70岁及以上激素受体阳性癌行前哨淋巴结活检。
  • 腋窝淋巴结清扫和切缘再切除的成功去实施与成本降低和以患者为中心结局改善相关。

临床怎么用

  • 临床应针对患者、医生和系统层面的障碍促进低价值手术的去实施,鼓励共享决策以减少过度治疗。

局限性

  • 关于70岁及以上女性前哨淋巴结活检高使用率相关因素的数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Overtreatment of early-stage breast cancer results in increased morbidity and cost without improving survival. Major surgical organizations participating in the Choosing Wisely campaign identified 4 breast cancer operations as low value: (1) axillary lymph node dissection for limited nodal disease in patients receiving lumpectomy and radiation, (2) re-excision for close but negative lumpectomy margins for invasive cancer, (3) contralateral prophylactic mastectomy in patients at average risk with unilateral cancer, and (4) sentinel lymph node biopsy in women 70 years or older with hormone receptor-positive cancer. OBJECTIVE: To evaluate the extent to which these procedures have been deimplemented, determine the implications of decreased use, and recognize possible barriers and facilitators to deimplementation. EVIDENCE REVIEW: A systematic review of published literature on use trends in breast surgery was performed in accordance with PRISMA guidelines. The Ovid, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane databases were searched for original research with relevance to the Choosing Wisely recommendations of interest. Eligible studies were examined for data about use, and any patient-level, clinician-level, or system-level factors associated with use. FINDINGS: Concordant with recommendations, national rates of axillary lymph node dissection for patients with limited nodal disease have decreased by approximately 50% (from 44% in 2011 to 30% to 34% in 2012 and 25% to 28% in 2013), and national rates of lumpectomy margin re-excision have decreased by nearly 40% (from 16% to 34% before to 14% to 18% after publication of a consensus statement). Conversely, national rates of contralateral prophylactic mastectomy continue to rise each year, accounting for up to 30% of all mastectomies for breast cancer (range in all mastectomy cases: 2010-2012, 28%-30%; 1998, <2%), and rates of sentinel lymph node biopsy in women 70 years or older with low-risk breast cancer are persistently greater than 80% (range, 80%-88%). Factors associated with high rates of contralateral prophylactic mastectomy use are younger age, white race, increased socioeconomic status, and the availability of breast reconstruction; limited data exist on factors associated with high rates of sentinel lymph node biopsy in women 70 years or older. Successful deimplementation of axillary lymph node dissection and lumpectomy margin re-excision were associated with decreased costs and improved patient-centered outcomes. CONCLUSIONS AND RELEVANCE: This review demonstrates variable deimplementation of 4 low-value surgical procedures in patients with breast cancer. Addressing specific patient-level, clinician-level, and system-level barriers to deimplementation is necessary to encourage shared decision-making and reduce overtreatment.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Wang T, Baskin AS, Dossett LA, et al. Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review. JAMA Surg. 2020. PMID: 32492121. doi:10.1001/jamasurg.2020.0322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。